v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Dec. 23, 2012
Dec. 25, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 9,176 $ 105,050
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 153,204 43,732
Deferred income taxes (19,337) (633)
Restructuring and impairment charges 1,021 866
Impairment of investment   1,724
Equity-based compensation expense 48,441 35,968
Income tax benefit on equity-based compensation plans   1,129
Excess tax benefit on equity-based compensation plans   (2,155)
Amortization of convertible note discount 15,595 13,264
Other, net 24,723 2,506
Changes in operating assets and liabilities 209,665 54,465
Net cash provided by operating activities 442,488 255,916
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures and intangible assets (82,889) (42,414)
Cash paid for business acquisition (8,716)  
Purchases of available-for-sale securities (628,074) (234,576)
Sales and maturities of available-for-sale securities 588,186 145,123
Purchase of equity method investment   (10,740)
Receipt of loan payment   8,375
Proceeds from sale of assets 660 2,677
Transfer of restricted cash and investments 179 20
Net cash used for investing activities (130,654) (131,535)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Principal payments on long-term debt and capital lease obligations (780) (3,140)
Excess tax benefit on equity-based compensation plans   2,155
Net cash paid in advance for stock repurchase contracts   (23,995)
Treasury stock purchases (710,089) (92,695)
Reissuances of treasury stock related to employee stock purchase plan 9,925 8,858
Proceeds from issuance of common stock 7,534 1,475
Net cash used for financing activities (693,410) (107,342)
Effect of exchange rate changes on cash 7,013 (2,243)
Net increase (decrease) in cash and cash equivalents (374,563) 14,796
Cash and cash equivalents at beginning of period 1,564,752 [1] 1,492,132
Cash and cash equivalents at end of period $ 1,190,189 $ 1,506,928
[1] Derived from audited financial statements